Eurofins Viracor creates separate BioPharma Services Business

Doug Irving, Marketing Manager, Eurofins Viracor BioPharma Services, dougirving@Viracor-Eurofins.com

Eurofins Viracor is excited to announce that as a result of the continued growth of both its Clinical Diagnostics and BioPharma Services businesses, Eurofins Viracor BioPharma Services has become a new legal entity, under Eurofins Scientific, as of 1 January, 2020.

With the impetus to operate both businesses at the highest level of customer service, this formal separation within the organisation enables the new entity to more fully focus, as a standalone business, on supporting its growing strategic BioPharma client partnerships - helping advance new therapies to market by expanding and enhancing timely, high-quality and accurate testing services across multiple phases of drug development.

Scott Mattivi, General Manager, will continue to lead Eurofins Viracor BioPharma Services to safeguard the rigorous scientific and quality standards that drug development companies have come to rely on for their clinical study needs.
“Our teams partner collaboratively with our sponsors to solve some of the toughest bioassay challenges, using our unique combination of state-of-the-art technology and extensive specialised expertise,” says Scott. “We are inspired every day to perform better, knowing patients are waiting for our timely, accurate, and sometimes life-saving test results.”

With location and contact information remaining the same, the only changes clients may notice will be a change to the logo on various communications. And visitors to the viracor-eurofins.com website will see incremental changes, as the companies move toward separate but linked sites for the Clinical Diagnostic and BioPharma businesses.
Eurofins Viracor BioPharma Services and Eurofins Viracor look forward to continued successful
partnerships with its valued clients.

For more information, visit: www.viracoreurofins.com/